Published in Medical Letter on the CDC and FDA, January 13th, 2002
Rotello's research could eventually be used to identify bioterror agents such as anthrax or smallpox, he says although the research team is currently working with benign substances, such as sugars and aspirin, as a way to hone the technology safely. The work also has applications in biomedicine, in creating new treatments and diagnostic techniques. The project is currently funded by a $950,000 grant from the National Institutes of Health.
Chemical sensors must meet...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.